1. |
Klein R, Klein B, Henkind P, et al. Retinal collateral vessel formation[J]. Invest Ophthalmol, 1971, 10(7): 471-480.
|
2. |
Spaide RF, Klancnik JM Jr, Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography[J]. JAMA Ophthalmol, 2015, 133(1): 45-50. DOI: 10.1001/jamaophthalmol.2014.3616.
|
3. |
Wong TY, Scott IU. Retinal-vein occlusion[J]. N Engl J Med, 2010, 363(22):2135-2144. DOI:10.1056/NEJMcp1003934.Wong TY, Scott IU. Retinal-vein occlusion[J]. N Engl J Med, 2010, 363(22):2135-2144. DOI:10.1056/NEJMcp1003934.
|
4. |
Henkind P. Retinal blood vessels. Neovascularization, collaterals, and shunts[J]. Aust J Ophthalmol, 1981, 9(4): 273-277. DOI: 10.1111/j.1442-9071.1981.tb00921.x.
|
5. |
张承芬, 陈有信. 视网膜静脉疾患[M]//张承芬. 眼底病学. 2版. 北京: 人民卫生出版社, 2010: 228-254.Zhang CF, Chen YX. Retinal vein diseases[M]//Zhang CF. Diseases of Ocular fundus. 2nd ed. Beijing: People's Medical Publishing House, 2010: 228-254.
|
6. |
Cole ED, Moult EM, Dang S, et al. The definition, rationale, and effects of thresholding in OCT angiography[J]. Ophthalmol Retina, 2017, 1(5): 435-447. DOI: 10.1016/j.oret.2017.01.019.
|
7. |
Suzuki N, Hirano Y, Tomiyasu T, et al. Collateral vessels on optical coherence tomography angiography in eyes with branch retinal vein occlusion[J]. Br J Ophthalmol, 2019, 103(10): 1373-1379. DOI: 10.1136/bjophthalmol-2018-313322.
|
8. |
Weinberg DV, Wahle AE, Ip MS, et al. Score study report 12 development of venous collaterals in the score study[J]. Retina, 2013, 33(2): 287-295. DOI: 10.1097/IAE0b013e318263d106.
|
9. |
Fuller JJ, Mason JO 3rd, White MF Jr, et al. Retinochoroidal collateral veins protect against anterior segment neovascularization after central retinal vein occlusion[J]. Arch Ophthalmol, 2003, 121(3): 332-336. DOI: 10.1001/archopht.121.3.332.
|
10. |
Lee HE, Wang Y, Fayed AE, et al. Exploring the relationship between collaterals and vessel density in retinal vein occlusions using optical coherence tomography angiography[J/OL]. PLoS One, 2019, 14(7): e0215790[2019-07-24]. https://pubmed.ncbi.nlm.nih.gov/31339897/. DOI: 10.1371/journal.pone.0215790.
|
11. |
Freund KB, Sarraf D, Leong BCS, et al. Association of optical coherence tomography angiography of collaterals in retinal vein occlusion with major venous outflow through the deep vascular complex[J]. JAMA Ophthalmol, 2018, 136(11): 1262-1270. DOI: 10.1001/jamaophthalmol.2018.3586.
|
12. |
Christoffersen NL, Larsen M. Pathophysiology and hemodynamics of branch retinal vein occlusion[J]. Ophthalmology, 1999, 106(11): 2054-2062. DOI: 10.1016/S0161-6420(99)90483-9.
|
13. |
Takahashi H, Nakagawa K, Yamada H, et al. Time course of collateral vessel formation after retinal vein occlusion visualized by OCTA and elucidation of factors in their formation[J/OL]. Heliyon, 2021, 7(1): e05902[2021-01-05]. https://pubmed.ncbi.nlm.nih.gov/33474512/. DOI: 10.1016/j.heliyon.2021.e05902.
|
14. |
Scott IU, Vanveldhuisen PC, Oden NL, et al. Baseline characteristics and response to treatment of participants with hemiretinal compared with branch retinal or central retinal vein occlusion in the standard care vs corticosteroid for retinal vein occlusion (SCORE) study: SCORE study report 14[J]. Arch Ophthalmol, 2012, 130(12): 1517-1524. DOI: 10.1001/archophthalmol. 2012.2728.
|
15. |
Spaide RF. Optical coherence tomography angiography signs of vascular abnormalization with antiangiogenic therapy for choroidal neovascularization[J]. Am J Ophthalmol, 2015, 160(1): 6. DOI: 10.1016/j.ajo.2015.04.012.
|
16. |
Montero-Moreno JA, Ruiz-Moreno JM. Collateral vessels after retinal vein occlusion treated with intravitreal bevacizumab[J]. Austin J Clin Ophthalmol, 2014, 1(6): 1028.
|